Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
DOI 10.1016/j.cell.2020.03.045

Cited by (1,009)

Items 801–900 of 1,009

  1. 2020 update on human coronaviruses: One health, one world
    Xinbin Zhao, Yuecheng Ding, Jing Du, Yubo Fan · 2020 · Medicine in Novel Technology and Devices
  2. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2
    Xiaoqiang Huang, Chengxin Zhang, Robin Pearce, Gilbert S. Omenn, Yang Zhang · 2020 · Journal of Proteome Research
  3. Data-driven molecular design for discovery and synthesis of novel ligands: a case study on SARS-CoV-2
    Jannis Born, Matteo Manica, Joris Cadow, Greta Markert, Nil Adell Mill, Modestas Filipavicius, Nikita Janakarajan, Antonio Cardinale, Teodoro Laino, María Rodríguez Martínez · 2021 · Machine Learning Science and Technology
  4. Comparison of the binding characteristics of SARS-CoV and SARS-CoV-2 RBDs to ACE2 at different temperatures by MD simulations
    Fang-Fang Yan, Feng Gao · 2021 · Briefings in Bioinformatics
  5. Scientific Hypothesis for Treatment of COVID‐19′s Lung Lesions by Adjusting ACE/ACE2 Imbalance
    Francesco Ferrara, Antonio Vitiello · 2021 · Cardiovascular Toxicology
  6. COVID-19 Infection and Circulating Microparticles—Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease
    Che Mohd Nasril Che Mohd Nassir, Sabarisah Hashim, Kah Keng Wong, Sanihah Abdul Halim, Nur Suhaila Idris, Nanthini Jayabalan, Dazhi Guo, Muzaimi Mustapha · 2021 · Molecular Neurobiology
  7. Modular Evolution of Coronavirus Genomes
    Yulia A. Vakulenko, Andrei A. Deviatkin, Jan Felix Drexler, Alexander N. Lukashev · 2021 · Viruses
  8. Possible mechanisms of cholesterol elevation aggravating COVID-19
    Yan Tang, Longtai Hu, Yi Liu, Bangyi Zhou, Xiaohuan Qin, Jujian Ye, Maoze Shen, Zhijian Wu, Peidong Zhang · 2021 · International Journal of Medical Sciences
  9. Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque
    Alireza Naderi Sohi, Jafar Kiani, Ehsan Arefian, Arezou Khosrojerdi, Zahra Fekrirad, Shokoofeh Ghaemi, Mohammad Kazem Zim, Arsalan Jalili, Nazila Bostanshirin, Masoud Soleimani · 2021 · Vaccines
  10. A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
    Xiaolei Cai, Min Chen, Aleksander Promiński, Yiliang Lin, Nicholas Ankenbruck, Jillian N. Rosenberg, Mindy Nguyen, Jiuyun Shi, Αναστασία Τοματσίδου, Glenn C. Randall et al. · 2021 · Advanced Science
  11. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
    Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, Mariana Cayres Vallinoto, Maria Alice Freitas Queiroz, Izaura Maria Vieira Cayres Vallinoto, Eduardo José Melo dos Santos, Carlos Alberto Marques de Carvalho, Antônio Carlos Rosário Vallinoto · 2022 · Frontiers in Microbiology
  12. The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
    Yixin Xie, Wenhan Guo, Alan E Lopez-Hernandez, Shaolei Teng, Lin Li · 2022 · Pathogens
  13. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
    Kairat Tabynov, Nurkeldi A. Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes I. Yespolov, Lei Li, Gourapura J. Renukaradhya, Nikolai Petrovsky, Kaissar K. Tabynov · 2022 · npj Vaccines
  14. Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses
    Zepeng Xu, Xinrui Kang, Pu Han, Pei Du, Linjie Li, Anqi Zheng, Chu‐Xia Deng, Jianxun Qi, Xin Zhao, Qihui Wang et al. · 2022 · Nature Communications
  15. Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
    Swati Bhat, P. Rishi, V. Chadha · 2022 · Virus Research
  16. Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2
    Hongshuai Wei, Congcong Zhang, Xin Du, Zhenguo Zhang · 2022 · Talanta
  17. Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
    Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte Kalveram, David Hughes Walker, Xuping Xie, Pei‐Yong Shi · 2023 · Emerging Microbes & Infections
  18. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics
    Gyanendra Bahadur Chand, Atanu Banerjee, Gajendra Kumar Azad · 2020 · Gene Reports
  19. An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
    Muhammad Zafar Irshad Khan, Adila Nazli, Hawaa Al-furas, Muhammad Imran Asad, Iqra Ajmal, Dildar Khan, Jaffer Shah, Muhammad Asad Farooq, Wenzheng Jiang · 2022 · Frontiers in Immunology
  20. ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes – evidence from a translational clinical and experimental approach
    Bing Han, Yibing Lv, Dominique Moser, Xiaoqi Zhou, Tobias Woehrle, Lianyong Han, Andreas Osterman, Martina Rudelius, Alexander Choukèr, Ping Lei · 2023 · EBioMedicine
  21. Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
    Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, Maryam Sadat Aleali, Narges Eslami, Mohammad Shenagari, Fariborz Mansour‐Ghanaei · 2024 · Heliyon
  22. Viral Metagenomic Next-Generation Sequencing for One Health Discovery and Surveillance of (Re)Emerging Viruses: A Deep Review
    Tristan Russell, Elisa Formiconi, Mícheál Casey, Maíre McElroy, Patrick W. G. Mallon, Virginie Gautier · 2025 · International Journal of Molecular Sciences
  23. PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19
    Giuseppe Palma, Teresa Pasqua, Giovannino Silvestri, Carmine Rocca, Paola Gualtieri, Antônio Barbieri, Anna De Bartolo, Antonino DE LORENZO, Tommaso Angelone, Ennio Avolio et al. · 2020 · Frontiers in Immunology
  24. Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
    Kenana Al Adem, Aya Shanti, Cesare Stefanini, Sungmun Lee · 2020 · Pharmaceuticals
  25. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
    Jyoti Kumar Verma, Naidu Subbarao · 2021 · Archives of Virology
  26. Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2
    Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda · 2021 · Biophysical Journal
  27. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2
    Billy J. Williams‐Noonan, Nevena Todorova, Ketav Kulkarni, Marie‐Isabel Aguilar, Irene Yarovsky · 2021 · The Journal of Physical Chemistry B
  28. SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
    Taha Azad, Ragunath Singaravelu, Emily E.F. Fekete, Zaid Taha, Reza Rezaei, Rozanne Arulanandam, Stephen Boulton, Jean‐Simon Diallo, Carolina S. Ilkow, John Cameron Bell · 2021 · Biosensors and Bioelectronics
  29. Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS‐CoV‐2 spike protein
    Cecylia S. Lupala, Xuanxuan Li, Jian Lei, Hong Chen, Jianxun Qi, Haiguang Liu, Xiao‐Dong Su · 2021 · Quantitative Biology
  30. Possible effects of air temperature on COVID‐19 disease severity and transmission rates
    Dominique Kang, Clifford Ellgen, Erik Benjamin Kulstad · 2021 · Journal of Medical Virology
  31. Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis
    Rong-Sui Gao, Wenhong Zu, Yang Liu, Jun-Hua Li, Zeyao Li, Yanling Wen, Hai-Yan Wang, Jing Yuan, Lin Cheng, Shengyuan Zhang et al. · 2021 · Virulence
  32. The Spike of SARS-CoV-2: Uniqueness and Applications
    Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flávia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid Jamaan Alzahrani, Aristóteles Goés‐Neto et al. · 2021 · Frontiers in Immunology
  33. Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis
    Adriana Albini, Luana Calabrone, Valentina Carlini, Nadia Benedetto, Michele Lombardo, Antonino Bruno, Douglas McClain Noonan · 2021 · Frontiers in Immunology
  34. Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
    Jiaqi Li, Zherui Zhang, Hong-Qing Zhang, Yanan Zhang, Xiang‐Yue Zeng, Qiu‐Yan Zhang, Cheng‐Lin Deng, Xiaodan Li, Bo Zhang, Han‐Qing Ye · 2021 · Signal Transduction and Targeted Therapy
  35. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
    Patthara Kongsuphol, Huan Jia, Hoi-Lok Cheng, Yue Gu, B. Shunmuganathan, Ming-Wei Chen, Sing-Mei Lim, S. Ng, P. Tambyah, H. Nasir et al. · 2021 · Communications Medicine
  36. SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
    Lin Yang, Jiacheng Li, Shuai Guo, Chengyu Hou, Chenchen Liao, Liping Shi, Xiaoliang Ma, Shenda Jiang, Bing Zheng, Yi Fang et al. · 2021 · International Journal of Molecular Sciences
  37. Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine
    Viviana Vásquez, Jahir Orozco · 2022 · Analytical and Bioanalytical Chemistry
  38. SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
    Mariana Valério, Luís Borges-Araújo, Manuel N. Melo, Diana Lousa, Cláudio M. Soares · 2022 · Frontiers in Medical Technology
  39. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
    Peng Sang, Yong-Qin Chen, Meng-Ting Liu, Yuting Wang, Ting Yue, Yi Li, Yi-Rui Yin, Liquan Yang · 2022 · International Journal of Molecular Sciences
  40. Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
    Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pažický, Joanna Pieprzyk, Michèle Sorgenfrei, Martin A. Schroer, Andrey Yu. Gruzinov, Cy Michael Jeffries et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  41. A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
    Wierbowski, Shayne D., Liang, Siqi, Liu, Yuan, Chen, You, Gupta, Shagun, Andre, Nicole M., Lipkin, Steven M., Whittaker, Gary R., Yu, Haiyuan · 2021 · Nature Methods
  42. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
    Gennady M. Verkhivker · 2020 · International Journal of Molecular Sciences
  43. Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-Mediated SARS-CoV-2 Entry
    Georgia Ragia, Vangelis G. Manolopoulos · 2020 · Pharmacogenomics
  44. Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants
    Zhennan Zhao, Yufeng Xie, Bin Bai, Chunliang Luo, Jingya Zhou, Weiwei Li, Yumin Meng, Linjie Li, Dedong Li, Xiaomei Li et al. · 2023 · Nature Communications
  45. Nanoparticles and Antiviral Vaccines
    Sen Liu, Meilin Hu, Xiaoqing Liu, Xingyu Liu, Tao Chen, Yiqiang Zhu, Taizhen Liang, Shiqi Xiao, Peiwen Li, Xiancai Ma · 2023 · Vaccines
  46. RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
    Asiya Kamber Zaidi, Puya Dehgani‐Mobaraki · 2021 · The Journal of Antibiotics · Retracted
  47. Dermaseptin-Based Antiviral Peptides to Prevent COVID-19 through In Silico Molecular Docking Studies against SARS-CoV-2 Spike Protein
    Taufik Muhammad Fakih · 2020 · Pharmaceutical Sciences and Research
  48. Structural investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib
    Nabil Al‐Zaqri, Thangaiyan Pooventhiran, Fahad A. Alharthi, Utsab Bhattacharyya, Renjith Thomas · 2020 · Journal of Molecular Liquids
  49. Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study
    Isaiah Ajibade Adejoro, Damilare David Babatunde, Gideon Femi Tolufashe · 2020 · Journal of Taibah University for Science
  50. SARS-CoV2 infectivity is potentially modulated by host redox status
    Jaswinder Singh, Rajinder S. Dhindsa, Vikram Misra, Baljit Singh · 2020 · Computational and Structural Biotechnology Journal
  51. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
    Loukia Yiangou, Richard P. Davis, Christine L. Mummery · 2020 · Stem Cell Reports
  52. Dynamic anti-spike protein antibody profiles in COVID-19 patients
    Yu-Jie Bao, Yun Ling, Yingying Chen, Di Tian, Guoping Zhao, Xianghui Zhang, Hong Hang, Li Yu, Bing Su, Hongzhou Lu et al. · 2020 · International Journal of Infectious Diseases
  53. Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips
    Dan Liu, Feng Ying Wu, Yu Cen, Lei Ye, Xueyin Shi, Yulan Huang, Shisong Fang, Lan Ma · 2021 · Molecular Immunology
  54. Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
    Arpita Devi, Nyshadham S. N. Chaitanya · 2021 · Molecular Diversity
  55. Computational analysis of functional monomers used in molecular imprinting for promising COVID-19 detection
    Hasan Çubuk, Mehmet Özbil, Pınar Çakir Hatir · 2021 · Computational and Theoretical Chemistry
  56. Development of Fast and Portable Frequency Magnetic Mixing-Based Serological SARS-CoV-2-Specific Antibody Detection Assay
    Jan Pietschmann, Nadja Voepel, Leonie Voß, Stefan Rasche, Max Schubert, Michael Kleines, Hans‐Joachim Krause, Tamlyn M. Shaw, Holger Spiegel, Florian Schröper · 2021 · Frontiers in Microbiology
  57. Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
    Danwei Yu, Yuanmei Zhu, Tao Jiao, Tong Tong Wu, Xia Xiao, Bo Qin, Huihui Chong, Xiaobo Lei, Lili Ren, Sheng Cui et al. · 2021 · Emerging Microbes & Infections
  58. Liver injury in COVID-19: Detection, pathogenesis, and treatment
    Yue Cai, Liping Ye, Ya-Qi Song, Xin‐Li Mao, Li Wang, Yanzhi Jiang, Weitao Que, Shao-Wei Li · 2021 · World Journal of Gastroenterology
  59. Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations
    Vikash Kumar, Haiguang Liu, Chun Fu Wu · 2021 · Computers in Biology and Medicine
  60. Current treatment strategies for COVID‑19 (Review)
    Fabin Han, Yanming Liu, Mei Mo, Juanli Chen, Cheng Wang, Yong Yang, Jibiao Wu · 2021 · Molecular Medicine Reports
  61. Antibody escape and global spread of SARS-CoV-2 lineage A.27
    Tamara Kaleta, Lisa Kern, Samuel Leandro Hong, Martin Hölzer, Georg Kochs, Julius Beer, Daniel Schnepf, Martin Schwemmle, Nena Bollen, Philipp Kolb et al. · 2022 · Nature Communications
  62. ACE2, B0AT1, and SARS-CoV-2 spike protein: Structural and functional implications
    Yuanyuan Zhang, Renhong Yan, Qiang Zhou · 2022 · Current Opinion in Structural Biology
  63. Photonics enabled intelligence system to identify SARS-CoV 2 mutations
    Bakr Ahmed Taha, Qussay Al-Jubouri, Yousif Ismail Mohammed Al Mashhadany, Mohd Saiful Dzulkefly Zan, Ahmad Ashrif A. Bakar, Mahmoud Muhanad Fadhel, Norhana Arsad · 2022 · Applied Microbiology and Biotechnology
  64. Significance of the RBD mutations in the SARS-CoV-2 omicron: from spike opening to antibody escape and cell attachment
    Md Lokman Hossen, Prabin Baral, Tej K. Sharma, Bernard S. Gerstman, Prem P. Chapagain · 2022 · Physical Chemistry Chemical Physics
  65. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
    Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, Aryan Aarabi, Zahra Payandeh, Masoumeh Rajabibazl · 2022 · Cellular & Molecular Biology Letters
  66. Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications
    Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El‐Saber Batiha, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar, Neha Sharma, Ajeet Kumar Kaushik et al. · 2023 · Pharmaceutics
  67. Balancing Functional Tradeoffs between Protein Stability and ACE2 Binding in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB Lineages: Dynamics-Based Network Models Reveal Epistatic Effects Modulating Compensatory Dynamic and Energetic Changes
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta · 2023 · Viruses
  68. Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
    Larysa V. Yevsieieva, Kateryna O. Lohachova, Alexander V. Kyrychenko, Sergiy М. Kovalenko, Vladimir V. Ivanov, Oleg N. Kalugin · 2023 · RSC Advances
  69. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2
    Omonike Arike Olaleye, Manvir Kaur, Collins Onyenaka · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  70. The Emergence and Spread of Novel SARS-CoV-2 Variants
    Huaimin Yi, Jin Wang, Jiong Wang, Yuying Lu, Yali Zhang, Ruihao Peng, Jiahai Lu, Zeliang Chen · 2021 · Frontiers in Public Health
  71. Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity
    Xin Luo, Kathleen M. McAndrews, Kent A. Arian, Sami J. Morse, Viktoria Boeker, Shreyasee V. Kumbhar, Yingying Hu, Krishnan K. Mahadevan, Kaira A. Church, Sriram Chitta et al. · 2024 · Journal of Controlled Release
  72. SARS-CoV-2: Zoonotic origin of pandemic coronavirus
    Štefan Vilček · 2020 · Acta Virologica
  73. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19
    Andrés López‐Cortés, Patricia Guevara‐Ramírez, Nikolaos C. Kyriakidis, Carlos Barba‐Ostria, Ángela León Cáceres, Santiago Xavier Guerrero, Esteban Ortiz‐Prado, Cristian Robert Munteanu, Eduardo Tejera, Doménica Cevallos-Robalino et al. · 2021 · Frontiers in Pharmacology
  74. Nicotinic Receptor Subunits Atlas in the Adult Human Lung
    Zania Diabasana, Jeanne‐Marie Perotin, Randa Belgacemi, Julien Ancel, Pauline Mulette, Gonzague Delépine, Philippe Gosset, Uwe Maskos, Myriam Polette, Gaëtan Deslée et al. · 2020 · International Journal of Molecular Sciences
  75. Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
    Samuel Ayodele Egieyeh, Elizabeth Oyebola Egieyeh, Sarel Malan, Alan Christofells, Burtram Clinton Fielding · 2021 · PLoS ONE
  76. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
    Asim Z. Abbasi, Dania A. Kiyani, Syeda M. Hamid, Muhammad Saalim, Ammad Fahim, Nasir Jalal · 2021 · Journal of Medical Virology
  77. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
    Umesh Kalathiya, Monikaben Padariya, Robin Fåhræus, Soumyananda Chakraborti, Ted R. Hupp · 2021 · Biomolecules
  78. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV
    Atanu Acharya, Diane L. Lynch, Ànna Pavlova, Yui Tik Pang, James C. Gumbart · 2021 · Chemical Communications
  79. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
    Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y. J. Zhang, Mirza S. Baig · 2021 · Drugs in R&D
  80. Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
    Shiqi Xu, Yifan Wang, Yanxing Wang, Chao Zhang, Hong Qin, Chenjian Gu, Rong Xu, Tingfeng Wang, Yong Ping Yang, Jinkai Zang et al. · 2021 · Emerging Microbes & Infections
  81. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
    Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian, Chonlaphat Sukasem · 2022 · Frontiers in Pharmacology
  82. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
    Chia‐Jung Li, Tai‐Ling Chao, Ting-Yu Chang, Chia-Chun Hsiao, De-Chao Lu, Yi-Wei Chiang, Guan-Chun Lai, Ya‐Min Tsai, Jun‐Tung Fang, Si‐Man Ieong et al. · 2022 · Microbiology Spectrum
  83. NO in Viral Infections: Role and Development of Antiviral Therapies
    Federica Sodano, Elena Gazzano, Roberta Fruttero, Loretta Lazzarato · 2022 · Molecules
  84. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells
    Simoun Icho, Edurne Rujas, Krithika Muthuraman, John Tam, Huazhu Liang, Shelby L. Landreth, Mingmin Liao, Darryl Falzarano, Jean‐Philippe Julien, Roman A. Melnyk · 2022 · Antimicrobial Agents and Chemotherapy
  85. Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
    Robert H. Shoemaker, Reynold A. Panettieri, Steven K. Libutti, Howard S. Höchster, Norman R. M. Watts, Paul T. Wingfield, Philipp M. Starkl, Lisabeth Pimenov, Riem Gawish, Anastasiya Hladik et al. · 2022 · PLoS ONE
  86. SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
    Lu Miao, Chunyu Yan, Yingzhu Chen, Wei Zhou, Xuelian Zhou, Qinglong Qiao, Zhaochao Xu · 2023 · Cell chemical biology
  87. Proteases and variants: context matters for SARS-CoV-2 entry assays
    Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Benhur Lee · 2021 · Current Opinion in Virology
  88. Flavonoids derived from medicinal plants as a COVID ‐19 treatment
    Mentor Sopjani, Francesca Falco, Federica Impellitteri, Valeria Guarrasi, Xuan Nguyen Thi, Miribane Dërmaku‐Sopjani, Caterina Faggio · 2024 · Phytotherapy Research
  89. AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Gennady M. Verkhivker · 2024 · Viruses
  90. A hybrid model integrating warm heat and ultraviolet germicidal irradiation might efficiently disinfect respirators and personal protective equipment
    Rajib Banerjee, Pulakesh Roy, Surajeet Das, Manash Kumar Paul · 2020 · American Journal of Infection Control
  91. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study
    Sai Chen, Hanting Liu, Tie Li, Rong Huang, Rong Gui, Junhua Zhang · 2020 · Upsala Journal of Medical Sciences
  92. In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2
    Yamil Liscano, José Oñate-Garzón, Iván Darío Ocampo-Ibáñez · 2020 · Molecules
  93. Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2
    Hualou Liang, Liang Yu Zhao, Xiajing Gong, Meng Hu, Hongbin Wang · 2021 · Clinical and Translational Science
  94. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides
    Frederico Campos Freitas, Paulo Henrique Borges Ferreira, Denize C. Favaro, Ronaldo Junio de Oliveira · 2021 · Journal of Chemical Information and Modeling
  95. Toward the prevention of coronavirus infection: what role can polymers play?
    X. Jiang, Zibiao Li, David James Young, Min Liu, Chuanliu Wu, Yun‐Long Wu, Xian Jun Loh · 2021 · Materials Today Advances
  96. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19
    Mohsen Ahmadi, Salar Pashangzadeh, Pegah Mousavi, Negin Saffarzadeh, Mohammad Amin Habibi, Fatemeh Hajiesmaeili, Nima Rezaei · 2021 · International Immunopharmacology
  97. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein
    Shweta Alai, Nidhi Gujar, Manali Joshi, Manish Gautam, Sunil Gairola · 2021 · Heliyon
  98. Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
    Michele Biagioli, Silvia Marchianò, Rosalinda Roselli, Cristina Di Giorgio, Rachele Bellini, Martina Bordoni, Anna Gidari, Samuele Sabbatini, Daniela Francisci, Bianca Fiorillo et al. · 2021 · Biochemical Pharmacology
  99. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
    Guillermo León, María Herrera, Mariángela Vargas, Mauricio Arguedas, Andrés Sánchez, Álvaro Segura, Aarón Gómez, Gabriela Solano, Eugenia Corrales‐Aguilar, Kenneth H. Risner et al. · 2021 · Scientific Reports
  100. SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
    Aixin Li, Kaitao Zhao, Bei Zhang, Rong-Hong Hua, Yujie Fang, Wuhui Jiang, Jing Zhang, Lixia Hui, Yingcheng Zheng, Yan Li et al. · 2021 · Journal of Virology